Chen Y, Zhang H, Zhao Y, Ma J
Front Oncol. 2022; 12:988798.
PMID: 36313636
PMC: 9603755.
DOI: 10.3389/fonc.2022.988798.
Reitere D, Masinska M, Lidaka L, Franckevica I, Baurovska I, Apine I
Radiol Case Rep. 2021; 17(2):368-372.
PMID: 34925667
PMC: 8649117.
DOI: 10.1016/j.radcr.2021.11.002.
Niida Y, Togi S, Ura H
Int J Mol Sci. 2021; 22(23).
PMID: 34884862
PMC: 8657641.
DOI: 10.3390/ijms222313060.
Serpieri V, DAbrusco F, Dempsey J, Cheng Y, Arrigoni F, Baker J
J Med Genet. 2021; 59(9):888-894.
PMID: 34675124
PMC: 9411896.
DOI: 10.1136/jmedgenet-2021-108114.
Duarte T, Teixeira S, Gonzalez-Reyes L, Reis R
Curr Oncol. 2021; 28(4):3058-3070.
PMID: 34436033
PMC: 8395412.
DOI: 10.3390/curroncol28040267.
Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).
Guerrini-Rousseau L, Smith M, Kratz C, Doergeloh B, Hirsch S, Hopman S
Fam Cancer. 2021; 20(4):317-325.
PMID: 33860896
PMC: 8484213.
DOI: 10.1007/s10689-021-00247-z.
CAR T Cell Therapy for Pediatric Brain Tumors.
Patterson J, Henson J, Breese R, Bielamowicz K, Rodriguez A
Front Oncol. 2020; 10:1582.
PMID: 32903405
PMC: 7435009.
DOI: 10.3389/fonc.2020.01582.
The Non-coding Side of Medulloblastoma.
Laneve P, Caffarelli E
Front Cell Dev Biol. 2020; 8:275.
PMID: 32528946
PMC: 7266940.
DOI: 10.3389/fcell.2020.00275.
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
Zou H, Poore B, Broniscer A, Pollack I, Hu B
Cancers (Basel). 2020; 12(3).
PMID: 32164294
PMC: 7139663.
DOI: 10.3390/cancers12030643.
Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway.
Huang D, Wang Y, Tang J, Luo S
Oncol Lett. 2018; 15(5):6077-6086.
PMID: 29725392
PMC: 5920380.
DOI: 10.3892/ol.2018.8142.
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis.
Infante P, Faedda R, Bernardi F, Bufalieri F, Lospinoso Severini L, Alfonsi R
Nat Commun. 2018; 9(1):976.
PMID: 29515120
PMC: 5841288.
DOI: 10.1038/s41467-018-03339-0.
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L, Dufour C, Varlet P, Masliah-Planchon J, Bourdeaut F, Guillaud-Bataille M
Neuro Oncol. 2017; 20(8):1122-1132.
PMID: 29186568
PMC: 6280147.
DOI: 10.1093/neuonc/nox228.
Hypomorphic Recessive Variants in SUFU Impair the Sonic Hedgehog Pathway and Cause Joubert Syndrome with Cranio-facial and Skeletal Defects.
De Mori R, Romani M, DArrigo S, Zaki M, Lorefice E, Tardivo S
Am J Hum Genet. 2017; 101(4):552-563.
PMID: 28965847
PMC: 5630196.
DOI: 10.1016/j.ajhg.2017.08.017.
A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.
Scollon S, Anglin A, Thomas M, Turner J, Schneider K
J Genet Couns. 2017; 26(3):387-434.
PMID: 28357779
DOI: 10.1007/s10897-017-0077-8.
Development of anticancer agents targeting the Hedgehog signaling.
Zhang X, Tian Y, Yang Y, Hao J
Cell Mol Life Sci. 2017; 74(15):2773-2782.
PMID: 28314894
PMC: 11107598.
DOI: 10.1007/s00018-017-2497-x.
Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery.
Srinivasan V, Z Ghali M, North R, Boghani Z, Hansen D, Lam S
Surg Neurol Int. 2017; 7(Suppl 44):S1135-S1141.
PMID: 28194300
PMC: 5299153.
DOI: 10.4103/2152-7806.196922.
Members of the Rusc protein family interact with Sufu and inhibit vertebrate Hedgehog signaling.
Jin Z, Schwend T, Fu J, Bao Z, Liang J, Zhao H
Development. 2016; 143(21):3944-3955.
PMID: 27633991
PMC: 5117142.
DOI: 10.1242/dev.138917.
Medulloblastoma: molecular pathways and histopathological classification.
Borowska A, Jozwiak J
Arch Med Sci. 2016; 12(3):659-66.
PMID: 27279861
PMC: 4889700.
DOI: 10.5114/aoms.2016.59939.
Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome.
Mann K, Magee J, Guillaud-Bataille M, Blondel C, Bressac-de Paillerets B, Yeatman J
Fam Cancer. 2014; 14(1):151-5.
PMID: 25287320
DOI: 10.1007/s10689-014-9752-1.
The prenatal origins of cancer.
Marshall G, Carter D, Cheung B, Liu T, Mateos M, Meyerowitz J
Nat Rev Cancer. 2014; 14(4):277-89.
PMID: 24599217
PMC: 4041218.
DOI: 10.1038/nrc3679.